Cowen, Long­wood add $735M to bio­phar­ma's pool of mon­ey

As bil­lions of dol­lars fun­nel in­to new heaps of dry pow­der for drug de­vel­op­ers, two more life sci­ences in­vest­ment firms can be added to the mix. Cowen Health­care In­vest­ments said Wednes­day morn­ing it closed a $555.6 mil­lion fund and Long­wood un­veiled a $180 mil­lion fund.

Cowen’s fourth fund will go to­ward mid- to-late stage bio­phar­mas, di­ag­nos­tics mak­ers and dig­i­tal health com­pa­nies, Cowen said. The group has more than $1 bil­lion un­der its man­age­ment, and it plans to bankroll both pri­vate and pub­lic com­pa­nies, adding to a port­fo­lio that’s al­ready 60-plus star­tups deep in health­care.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER